What Are Art Tablets Used for in Urine Tests
Child Adolesc Psychiatr Clin N Am. Author manuscript; available in PMC 2017 Jul ane.
Published in last edited course every bit:
PMCID: PMC4920965
NIHMSID: NIHMS764832
OBJECTIVE TESTING – URINE AND OTHER DRUG TESTS
Scott Due east. Hadland
1Boston Children'due south Infirmary, Partitioning of Adolescent / Young Adult Medicine, Boston Children's Hospital, Division of Developmental Medicine, Department of Medicine, 300 Longwood Avenue, Boston, MA, USA, 02115
3Harvard Medical School, Department of Pediatrics, 25 Shattuck St., Boston, MA, USA, 02115
Sharon Levy
2Department of Medicine, 300 Longwood Avenue, Boston, MA, Us, 02115
iiiHarvard Medical School, Department of Pediatrics, 25 Shattuck St., Boston, MA, USA, 02115
Abstruse
Drug testing, when advisedly collected and thoughtfully interpreted, offers a critical adjunct to clinical care and substance use treatment. All the same, because test results can be misleading if not interpreted in the correct clinical context, clinicians should always deport a careful interview with adolescent patients to understand what testing is likely to show and then utilise testing to validate or refute their expectations. Due to the ease with which samples tin be tampered, providers should also carefully reflect on their own collection protocols and sample validation procedures to ensure optimal accuracy.
Keywords: Substance corruption detection, adolescents, substance-related disorders, ethanol, street drugs, urine
It is incumbent on clinicians to observe substance employ early and intervene to reduce acute risks and to improve the life class trajectory of addiction and its harms. For clinicians working with adolescents, screening for alcohol and drug employ is a disquisitional skill that allows for brief intervention and referral to treatment, an approach endorsed by major professional bodies [ane–3] including the American Academy of Pediatrics (AAP) [4]. Screening is all-time conducted using a validated instrument (such as the S2BI instrument [5]) that tin then prompt a word betwixt the clinician and adolescent.
At first chroma, routine screening of adolescents by testing urine or other actual fluids might seem like a reasonable strategy for detecting substance use, but this approach is fraught with inaccurate findings and misinterpretation, and worse, leads to mistrust on the part of the boyish and missed opportunities for nuanced discussions about substance utilize with a clinician. Abstinence from all substances is recommended throughout adolescence considering of the impact of alcohol, marijuana and other drugs on brain evolution [6]. Routine drug testing of all adolescents, however, is insensitive for detecting desultory use, and risks obscuring opportunities for counseling and brief interventions that may be meliorate identified by self-report [7].
While routine laboratory testing is not recommended for adolescents in that location are several indications for which this procedure may provide useful information to supplement a clinical history or to regularly monitor patients in treatment for substance use disorders. Hither, we review drugs normally included in testing panels, bodily fluids and tissues tested, indications for testing, practical concerns, and problems unique to drug testing adolescents as contrasted with its utilise in adults.
Drugs tested
Although it is possible to examination for utilize of an individual drug, multiple drugs or classes are usually tested at the same time using a single biological sample [eight]. The virtually commonly used immunoassay (IA) drug test panel includes the "SAMHSA-5", a standard panel established in the 1980s under the Drug-Gratuitous Workplace Act. The SAMHSA-5 includes amphetamines, marijuana (tetrahydrocannabinol [THC]), cocaine metabolites, opiates (including heroin, morphine, and codeine, but not synthetic opioids such as oxycodone, hydrocodone, buprenorphine, or methadone), and phencyclidine (PCP) [8,9]. Most drug screens available commercially have panels that expand across the SAMHSA-v to besides include benzodiazepines, barbiturates, and additional opiates [eight].
Alcohol and drugs vary substantially in their windows of detection, largely owing to their degree of fatty solubility. For example, THC and other highly fat-soluble compounds have a very long half-life of elimination and can be detected in urine up to weeks after last use amidst heavy users). The various windows of detection for a number of commonly used substances are shown in Table 1 [10].
TABLE ane
Windows of detection in urine for diverse substances.
| Detection Windows by Drug Examination Type | ||||
|---|---|---|---|---|
| Substance | Urine | Hair | Oral Fluid | Sweat |
| Alcohol | 10-12 hours | N/A | Upwardly to 24 hours | Northward/A |
| EtG -- Up to 48 hours | ||||
| | ||||
| Amphetamines | 2 to 4 days | Upward to 90 days | 1-48 hours | seven-fourteen days |
| | ||||
| Methamphetamine | ii to v days | Upwardly to ninety days | 1-48 hours | 7-fourteen days |
| | ||||
| Barbiturates | Up to 7 days | Up to 90 days | N/A | N/A |
| | ||||
| Benzodiazepines | Upward to vii days | Upwardly to 90 days | N/A | Due north/A |
| | ||||
| Cannabis (Marijuana) | 1-30 days | Up to 90 days | Up to 24 hours | 7-14 days |
| | ||||
| Cocaine | one to B days | Upwards to xc days | i-36 hours | seven-14 days |
| | ||||
| Codeine (Opiate) | two to 4 days | Up to 90 days | 1-36 hours | 7-14 days |
| | ||||
| Morphine (Opiate) | 2 to five days | Up to 90 days | 1-36 hours | 7-14 days |
| | ||||
| Heroin (Opiate) | 2 to three days | Up to xc days | i-36 hours | 7-fourteen days |
| | ||||
| PCP (Phencyclidine) | five to half dozen days | Up to 90 days | N/A | vii-fourteen days |
Sources for testing
There are multiple sources for biologic specimens (frequently referred to as "biological matrices" in the scientific literature): urine, blood, saliva, hair, breath, sweat, and meconium. These various tissues and bodily fluids showroom different rates and durations of excretion that result in different detection windows for substances, every bit demonstrated in Effigy 1.
Drug detection times for different biologic specimens used in drug testing.
*Very broad estimates that also depend on the substance, the corporeality and frequency of the substance taken, and other factors previously listed.
†Every bit long as the patch is worn, ordinarily 7 days.
‡7–x days after use to the time passed to grow the length of hair, merely may exist limited to 6 months pilus growth. Even so, nigh laboratories analyze the corporeality of pilus equivalent to three months of growth.
When substances are ingested, they are absorbed in the gastrointestinal tract and distributed to tissues of the body [9]. Substances that are injected, inhaled or snorted featherbed gastrointestinal absorption and are delivered immediately to tissues. Since many drugs are lipid soluble, they must undergo metabolism in the liver to return them h2o soluble which then allows them to be eliminated in urine. Claret and breath reflect moment-to-moment serum levels of an ingested substance, and offer the earliest and shortest windows of detection for substances [viii]. Sweat and saliva reverberate the presence of a drug within the body several hours later. Urine offers a somewhat longer window of detection for substances, usually varying from one day subsequently consumption to several weeks. Hair and meconium offering the longest windows of detection (weeks to months). Advantages and disadvantages of dissimilar matrices for drug testing are shown in Table 2.
Tabular array 2
Advantages and disadvantages of various matrices (i.e., bodily fluids and tissues) used for drug testing.
| a | ||
|---|---|---|
| Matrix | Advantages | Disadvantages |
| Urine |
|
|
| Oral Fluid |
|
|
| Sweat |
|
|
| Blood |
|
|
| b | ||
| Hair |
|
|
| Breath |
|
|
| Meconium |
|
|
Here we review the various biologic matrices for drug testing:
(1) Urine
Of all the matrices, urine is the almost normally used for adolescent drug testing and is the most thoroughly studied [9,11]. However, for an adolescent patient, its drove is somewhat invasive since it requires either a sophisticated collection protocol which is not readily available in medical offices or direct observation (east.chiliad., by a clinician or a parent) to prevent tampering [seven,12]. Compounding this, many pediatricians are unfamiliar with proper drove procedures and with the limitations of urine drug screening [11].
Currently, the nigh commonly used urine drug testing approach involves automated immunoassay either alone as a point-of-care test or as an initial screen for a 2-step testing process [vii,eight]. Results from IA are qualitative (i.e., a drug or its metabolite is denoted either nowadays or absent, without the quantity reported). In the 2-step approach, a screening IA is followed by confirmatory gas chromatography-mass spectrometry (GC-MS). If whatsoever substances are positive on the initial IA, a separate quantity of the same sample is then subjected to GC-MS as a confirmatory examination for those aforementioned substances, with negative results on the IA disregarded. GC-MS provides a quantitative consequence to assistance guide the clinician, which can be used to follow serial samples and determine whether the metabolite concentration is ascension or falling, which may suggest ongoing use or forbearance, respectively. Fifty-fifty yet, caution is warranted as levels may vary with urine concentration, the amount of drug used, and fourth dimension since final use, thus making an absolute decision regarding whether apply is ongoing difficult.
IA is often used as a point-of-intendance examination given its convenience, low price, and relatively rapid results (although results are oft not available quickly enough to guide clinical management in emergent situations) [vii]. Almost dwelling house urine drug test kits use IA. Although IA has loftier sensitivity, information technology has poorer specificity than GC-MS owing to cross-reactivity, whereby compounds in the biologic specimen other than the actual substance or its metabolite bind to the assay and trigger a faux-positive result. (For instance, PCP assays tin plough positive if an individual consumes dextromethorphan, a common component of cough syrup.) Additionally, IA drug tests performed in isolation practice not distinguish among drugs within a class (i.e., IA cannot distinguish between diverse amphetamines, barbiturates, benzodiazepines, or opiates) [8]. GC-MS is not performed as a signal-of-care test and usually must exist sent to a laboratory, resulting in a delay [7]. Newer but less widely used technologies include liquid chromatography-mass spectrometry and tandem mass-spectrometry, which tin can be used to bypass the initial screening IA and identify a larger number of substances and metabolites [eight].
Often, laboratories written report the urine creatinine, which helps the clinician correct for the relative concentration or dilution of the urine. Concentration of the urine past the kidneys results in elevated levels of drug metabolites; therefore, urine concentrations of certain drugs and their metabolites are usually divided past the urine creatinine. An example of this is THC, whose excretion in the urine can go on for upwards to one calendar month after almost recent use in heavy users [thirteen], and urine samples positive for THC must exist carefully interpreted to distinguish ongoing excretion from new apply. Urine THC concentration should exist divided by the urine creatinine concentration in social club to determine whether the creatinine-normalized THC concentration is increasing or decreasing with sequent urine samples [14] and these ratios can and then exist compared to nomograms of THC excretion in social club to make a clinical interpretation [15]. Practical issues, such as timing of the urine sample drove, specimen collection techniques, validation of the sample, and result interpretation are covered later in this chapter.
(two) Blood
Drug testing of blood samples is usually only performed in emergency situations, and due to the invasiveness of obtaining a blood sample, the need for specially trained phlebotomists, and the expense of blood drug testing, information technology is rarely performed in principal care settings [vii,nine]. An additional limitation is that obtaining blood samples requires venipuncture and locating venous admission amid injection drug users can be very difficult [9]. Unlike urine samples, blood samples generally detect alcohol and drug compounds themselves rather than their metabolites. Claret testing typically detects substance utilize that occurred within 2 to 12 hours of the test [seven].
(three) Oral (saliva)
Oral fluid testing is less usually used but oral samples represent a user-friendly, promising matrix for many settings. Unlike urine samples, oral samples are not hands tampered with, and can be collected with minimal invasion of privacy [15,16]. Oral secretions contain either the original drug compound or its metabolite for approximately 24-48 hours later terminal use [ix,15,16]. Importantly, use of jiff sprays, mouthwash or other oral rinses containing alcohol does not affect drug testing result as long every bit they are not used inside 30 minutes of sample collection [17]. To collect an oral sample, a swab is placed adjacent to the lower gums confronting the inner cheek and left in place for several minutes before being inserted into a vial for transportation to the laboratory [9]. Indicate-of-care oral testing is besides available in some settings [18].
(4) Hair
Hair drug tests accept the reward of detecting substance use days to months, or in some cases, years, later [9,19]. Drug metabolites are present in pilus as early on every bit one week later most contempo utilise, and because metabolites remain trapped in the core of the hair as it grows, hair provides a rough timeline of apply over an extended menses [9,20]. Hair grows at a rate of approximately one-half inch per month, and so the standard 1.5-inch hair sample obtained shut to the root in most drug testing protocols gives information over past 3-calendar month drug use [eight].
Because of the long menstruation of detection for hair samples, they are useful for detecting chronic substance employ, agreement the elapsing of a patient'southward drug utilise over the long term, and indicating periods of abstinence [twenty–22]. Conversely, hair testing is non helpful in detecting sporadic apply when weekly or even monthly drug testing is required as office of a drug treatment plan [nine]. Additionally, drug use often must relatively heavy in order for testing to find levels in hair. Other limitations of hair testing include that individuals can surreptitiously remove the sample through shaving, that sweat product can crusade drug metabolites to travel proximally up the pilus shaft thus affecting drug test interpretation, and that drugs tin exist incorporated into hair through simple exposure from 2d-manus fume [23,24]. An additional potential consideration is that drug concentrations can be affected by the melanin content of hair, resulting in potentially college concentrations of sure drugs in dark hair as compared to blond or red pilus [15,25]. Bleaching or coloring the hair may also modify concentrations of metabolites [26].
The hair sample is typically cutting from the back of the head using pair of scissors, cut as shut to the scalp as possible to approximate most recent drug employ [9]. For patients who are bald or who have shaved their head, hair can be taken from the armpit, face, or other unshaven function of the trunk, then long as a sufficiently long enough sample can be taken. No point-of-intendance hair drug testing currently exists.
(v) Breath
Jiff testing, ofttimes referred to colloquially equally the "Breathalyzer" test after the original brand proper noun testing device, is used exclusively for instantaneous estimation of blood booze content [8]. Breath testing provides an accurate measure of the actual claret alcohol content at that moment in time, and is more frequently used in law enforcement or in emergency departments than in chief care. The U.s. Department of Transportation maintains an active list of approved breath testing devices for the interested reader (https://www.transportation.gov/odapc/approved-evidential-breath-testing-devices) [27].
(half dozen) Sweat
The US Food and Drug Administration (FDA) has approved a patch for collection of sweat for drug testing that is placed on the skin for iii-7 days prior to being sent to a laboratory for interpretation [8,9]. In Europe. a wipe is also bachelor that is non currently FDA-approved due to concerns regarding its accuracy [nine,12]. Sweat testing checks for substances and their metabolites in the bloodstream in the hours before and during the time that the patch is practical [8,9]. Currently, sweat testing is only available for the SAMHSA-5. Patches that pucker or show other evidence of interference when removed accept been designed in attempt to reduce tampering [8].
(7) Meconium
Meconium is obtained from newborns and used as a mensurate of maternal substance use in the 3rd trimester [eight,12,28,29]. Meconium is nowadays in a newborn's first several stools. Meconium testing is used as a screen in the newborn nursery or neonatal intensive intendance unit when maternal substance use during pregnancy is suspected, and can have critical legal consequences for guardianship of the kid [xxx]. Meconium testing can also inform clinical management of neonatal abstinence syndrome and other newborn withdrawal syndromes.
Indications for drug testing
Co-ordinate to the American Society for Addiction Medicine (ASAM), drug testing should be used "to discourage nonmedical drug use and diversion of controlled substances, to encourage appropriate entry into addiction treatment, to place early relapse and to improve outcomes of addiction treatment through the utilise of long-term post-treatment monitoring." Since substance use is often hole-and-corner, adolescents may non forthcoming and drug testing may exist useful when history is negative in the context of clinical signs and symptoms suggesting substance use. [7]. Indications for adolescent drug testing are explored here.
(ane) Emergent care
Drug tests are usually used in emergent situations, such as when an adolescent presents with altered mental status [7,eight]. Some common clinical scenarios include attempted suicide, motor vehicle injury or other injury in which substance use may accept been a contributor, unexplained seizures, syncope, arrhythmia, or toxidromal signs that propose a particular intoxication or withdrawal pattern [7]. In such cases, consent for the drug screen is inferred, and its results may exist used to guide clinical management. However, drug testing results are more often than not not available immediately and cannot reliably exist used early on in emergent management; therefore, initial decisions, such every bit whether to provide naloxone for suspected opioid overdose should be made by the clinician based on presenting signs and symptoms [seven,8]. Additionally, because highly sensitive drug testing may detect substances at limits far lower than therapeutic doses, drug screens may identify additional substances that are present but non contributing to the acute intoxication or withdrawal picture and may therefore exist misleading [7]. Once the patient is stabilized, withal, drug testing results may exist helpful in determining subsequent direction, specially once confirmatory testing results are available.
(2) Cess of behavioral or other mental health concerns
In primary care or mental wellness care settings, substance use by an adolescent may be suspected as underlying or complicating symptoms of low, anxiety, inattention, hyperactivity, or other broader concerns such as a school failure or interpersonal difficulties [7,nine]. In these situations, voluntary drug testing (i.e., drug testing with the assent of the boyish and the consent of a guardian) may serve every bit a helpful complement to a conscientious history. A positive drug screen might indicate substance utilize that an adolescent previously denied, leading to an opportunity for an honest chat [7]. However, as highlighted below in the discussion of interpretation of results, in that location are a number of limitations in drug testing that might result in a negative event despite clinically meaning substance use by an adolescent.
(3) Substance utilize handling
Drug testing is performed as a routine component of outpatient boyish substance use treatment [vii,9]. Information technology serves multiple roles, including preventing adverse effects of pharmacotherapy (east.k., precipitating opioid withdrawal if a clinician provides naltrexone for alcohol use disorder if that patient were also surreptitiously using opioids), and monitoring for use of illicit substances during handling and/or adherence with prescribed medications. such equally stimulants for comorbid attending deficit hyperactivity disorder (ADHD) or buprenorphine for opioid use disorder [9]. In residential substance utilise treatment, drug testing helps back up the drug-costless therapeutic surround [viii].
In monitoring for illicit drug use during treatment, testing should be performed at random times, every bit discussed below, since adolescents are often knowledge of the brusk window of detection in urine for many substances and might otherwise merely abstain from utilize for the several days leading up to a scheduled test [7,nine]. Testing should as well be performed frequently plenty (e.thou., at least weekly) to detect any use occurring during treatment [eight]. A positive drug screen should never serve as grounds for termination from the substance employ treatment plan, but rather should prompt a conscientious conversation betwixt the boyish and clinician to reconsider the current treatment plan [7,8]; multiple positive drug tests may indicate the need for a higher level of care, for example [8].
Contingency management, which relies on incentives to encourage ongoing abstinence for adolescents with a substance use disorder, often uses drug testing for monitoring [31]. Adolescents who attend their scheduled visits and/or have negative urine drug tests are provided monetary prizes or other rewards to reinforce their treatment program adherence [9,31,32]. In many settings, the value of prizes increases incrementally with each successive attended visit or negative drug screen, which further improves the efficacy of treatment [31,33,34].
(iv) Other settings
A number of other potential settings for adolescent drug testing exist. Workplace drug testing is federally mandated by the Section of Transportation (DOT) for private-sector transportation workers, and many of the current standards for workplace testing have emerged from these regulations [9]. For example, the SAMHSA-5 urine drug screen was codified in the late 1980s for DOT workplace testing. Some adolescents and immature adults may observe themselves seeking or maintaining employment in settings where drug screening is routine [seven]. Drug screens from non-federal employers can and often do expand their drug testing panels to include substances in addition to those on the SAMHSA-5 [9]. Many policies regarding when, where and how employers tin can test their employees are set up by states; a full review is beyond the telescopic of this article merely a complete, upwards-to-engagement listing of relevant policies is available at a cost from the Drug and Alcohol Testing Industry Association (DATIA), an contained industry organization [35].
Some jurisdictions accept proposed drug screening in school. Nonetheless, this arroyo is opposed past the AAP due to insufficient evidence that it discourages adolescent drug use, difficulty in correctly interpreting results, and potential agin consequences such equally disciplinary action, decreased participation in sports and other school activities, breaches of confidentiality, and increased use of substances not included in the drug testing panel used [36]. Similarly, although dwelling urine drug tests are commercially bachelor for purchase from, for example, drugstores and online marketplaces, use of these 'over-the-counter' home tests by parents without the guidance of a clinician is non recommended due to the complexities in interpreting results [7]. (Utilise of over-the-counter drug screens is distinguished from formal drug screens collected at home nether the guidance of a clinician to be sent to an approved laboratory, which is often recommended as part of drug treatment.) Youth involved in the criminal justice system are typically routinely drug tested and the specifics of this practice vary from state to state [8].
Practical concerns in adolescent drug testing
(1) Adolescent assent / parental consent, and confidentiality
One time a practitioner feels that drug testing (usually urine) would be helpful clinically, he or should have a careful discussion with both the adolescent and parent regarding the potential benefits (i.e., supporting reducing substance use) and the limitations of testing [7]. Whatever questions should be addressed, and then the clinician should communicate to the adolescent the recommendation for drug testing, emphasizing the potential benefits (confirming a history of no recent substance use, improving trust with parents, etc.). Assent should ever be obtained from the adolescent, and permission to share results of any drug tests with his or her parent should be sought.
In improver to the usual privacy provisions dictated by the Health Insurance Portability and Accountability Human action of 1996 (HIPAA), programs providing substance use diagnosis, treatment, or referral for treatment are subject area to stricter confidentiality requirements under federal regulations [ix]. These regulations are independent in Book 42 of the Code of Federal Regulations, Function two (42 CFR Role two) – frequently referred to by practitioners every bit "Part ii" provisions. Whereas under HIPAA, personal health information can be disclosed amongst an adolescent's providers without written consent if done every bit office of routine clinical care, Part two requires written permission from the boyish patient for any disclosure. As ever, if emergent clinical care for the adolescent is required, consent is implied and written permission need not exist obtained. Many readers of this chapter are unlikely to be affected by Function two regulations.
The historic period at which an adolescent can independently seek, consent for, and receive substance use treatment services varies from land to country [37]. In some cases, a small-scale's emotional, social and cognitive maturity is considered in addition to chronologic age. Moreover, whether an adolescent'southward parent must by law be notified once the adolescent has consented for treatment varies beyond states. Readers are encouraged to seek out regulations in their own states; the National District Attorneys Association (NDAA) compiles a listing of relevant country laws and regulations that providers can review [38].
(2) Exam option and timing
The clinician should too carefully consider what tests should exist included in a drug screen. The SAMHSA-5, though widely available, notably misses a number of commonly used substances, including booze, opioids and constructed cannabinoids, among other drugs and their metabolites [39]; clinicians should ensure that the laboratory they piece of work with is able to broadly test for these commonly used substances. The SAMHSA-5 also tests for certain substances that are not usually used in many places in the U.s.a.. An instance is phencyclidine (PCP), which is included in the SAMHSA-5 despite very low prevalence of use in nearly settings. In fact, where prevalence is low, a positive PCP screen is likely to be simulated, having been triggered by cantankerous-reactivity by with some other compound (e.chiliad., dextromethorphan, a component of many cough syrups, is often implicated; even though technically a false positive, such a result may indicate misuse of cold medications) [twoscore].
For adolescents who employ marijuana, metabolites are detected in the urine for longer than for other substances attributable to the fat solubility of cannabinoids. For intermittent users, metabolites can be detected in the urine for upwardly to one week afterwards last use; for daily users, they can be detected for up to one month [13]. For adolescents who beverage alcohol, urine ethyl glucoronide (ETG) and ethyl sulfate (ETS) are helpful tests with a window of detection of several days. Liver tests, such as asparate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) too are also somewhat sensitive to alcohol use, but have poor specificity thus limiting their use [41]. Carbohydrate-scarce transferrin (CDT) is a more than specific marker for ongoing heavy booze use, but requires drinking in backlog of 40 1000/day of ethanol for several weeks (approximately iii standard drinks/24-hour interval), and may not accurately detect intermittent heavy drinking.
Random drug testing is preferred to scheduled drug testing [eight]. Since the window of detection for most substances varies between 1 to three days, adolescents who hope to evade detection on a drug test simply need to abjure from substance utilize for several days beforehand (though a longer period of abstinence is required for marijuana, as highlighted above). Random testing entails notifying the adolescent (or preferably, the adolescent's parent or guardian) of an immediate testing fourth dimension. Carefully counseling the adolescent and his or her family beforehand about the expectation to immediately complete random drug tests as part of the treatment plan is essential. Random tests should occasionally be done on consecutive days to avoid drug use immediately afterward testing.
(3) Specimen collection
Proper specimen drove procedures are critical for ensuring an adequate urine sample for drug testing. The internet provides advice on a host of mechanisms for defeating urine drug tests that range from simple to sophisticated. A survey of practicing pediatricians found that while the large majority accept ordered urine drug tests for an boyish patient, most ofttimes these tests are collected without supervision, making it relatively easy for an adolescent to defeat a test [11].
The most easily accomplished methods for tampering with a urine sample are adding water or other fluids or substituting a previously nerveless sample. Unproblematic specimen validity checks (described below) tin can identify nearly samples that have been adulterated. Withal, supervised sample collection is recommended to discourage tampering and increase the utility of testing.
The DOT describes two adequate methods for collecting a urine sample for drug testing [12]. For most routine workplace testing with adults, a collection protocol is used that does not involve directly observation. In this protocol, urine samples are nerveless in a private bath without running h2o, soap, or other liquids, and with toilet water stained bluish. No outer clothing, bags or brief cases are permitted in the bathroom. The sample is checked for temperature immediately after it is produced. While constructive, this protocol is expensive to implement and monitor. Some commercial laboratories may offer this service, though information technology must be ordered separately and adds meaning expense to the price of a test, which may not be covered by insurance.
An alternative acceptable collection method requires directly observation of the specimen equally it is existence produced. This method is more invasive, though is simpler and does not require a specialized bathroom. This alternate drove protocol is often not applied in a clinical function.
For adolescents receiving treatment for substance use problems or disorders, urine specimens can be nerveless at home under the supervision of a parent or guardian. First morning specimens are recommended because the bladder is reliably full and urine is most concentrated. Random, unannounced tests are difficult to prepare for and repeated testing over several weeks is likely to detect ongoing utilize. A series of negative drug tests over several weeks provide strong back up for a report of forbearance. Thus home urine collection may be a reasonable mechanism for monitoring an adolescent that is receiving handling for a substance utilise disorder.
While urine specimens may exist collected at dwelling, information technology is recommended that all urine drug tests exist coordinated with a medical professional and only ordered in the context of an advisable clinical indication. As noted before, the AAP recommends against suspicionless drug testing – whether at domicile, school, medical offices or in other settings – because these tests provide little useful clinical information and may cause tension between an boyish and parents, schoolhouse administrators, physicians, or other adults. Furthermore, the AAP discourages physicians from recommending drug tests for habitation use interpreted past families because they rely on relatively non-specific and insensitive enzyme linked panels and may generate false-positive and false-negative results. (Once again, this is distinguished from abode collection of drug tests to be sent to a laboratory for formal interpretation under the guidance of a clinician in a substance use handling programme, which is commonly indicated.)
(4) Specimen validation
Regardless of collection procedures, validity checks are recommended for all urine specimens. The DOT recommends checking temperature, creatinine and specific gravity on every urine sample [12]. Temperature is checked immediately after voiding. Urine specimen cups with temperature strips that fluoresce betwixt 90 and 100 degrees Fahrenheit facilitate temperature validation. Urine creatinine and specific gravity can be ordered together with a drug test panel. Many commercial labs also offering adulterant panels that tin detect many substances added to a test in vitro.
Creatinine is a product of muscle metabolism that can be used every bit a mark of urine concentration. According to DOT guidelines, urine samples with a random creatinine between 2 and twenty mg/mL should exist considered dilute; a specimen with a creatinine less than two mg/mL should be considered substituted (i.e., not urine) or artificially diluted (i.e., water has been added) [12]. Since adolescence is the menses in life during which muscle mass is greatest, this creatinine range may need to be adjusted for larger teens. For example, a specimen with a creatinine between xx and 50 mg/mL may be considered dilute if the specific gravity is also low.
A dilute specimen suggests that a teen has recently consumed a large volume of fluid. This may occur incidentally or intentionally in endeavor to drive the concentration of a drug or metabolite beneath the detection level of the test. It is not possible to distinguish between these possibilities based on the results of a urine test lone, and clinical correlation is advised whenever interpreting negative drug test. Repeat drug testing may be warranted using first morning specimens if possible. A dilute urine sample can still be positive, although in such cases it is possible to miss other substances present in lower concentrations. For case, a urine specimen may be positive for marijuana but besides dilute to identify low levels of cocaine.
(5) Interpretation of results
As with all laboratory tests, urine drug tests tin can yield false positive and false negative results. Different most other laboratory results, however, results of urine drug tests tin be accurate and still yield misleading information – in other words a examination can yield a true negative effect in the context of ongoing psychoactive substance employ (due east.thou., if the exam was performed outside the window of detection of the drug that the boyish was using), or a truthful positive result in the context of no use of psychoactive substances (e.g., if the test detects substances found in food such equally poppy seeds, which can trigger an opioid screen, or in a patient'due south prescribed medications such equally stimulants for ADHD, which tin trigger an amphetamine screen). Urine drug tests may besides yield ambiguous results if a exam is likewise dilute for interpretation, or does not friction match a patient'southward stated history. Because of their differing properties, different interpretation strategies are required for IA screening tests every bit compared to confirmatory GC-MS tests.
a. Interpretation of IA tests
Enzyme-linked IA tests are relatively quick, inexpensive, and easy to perform and as such are oft used past laboratories equally a first line screen. This testing format identifies drugs or metabolites above a sure threshold concentration in the urine. Typically the threshold concentration is ready high enough to limit detection of depression levels of drugs or metabolites that may be institute in foods. For instance, poppy seeds comprise very low levels of morphine that can be detected by sensitive tests, simply nether usual circumstances concentrations of morphine in the blood and urine from consuming typical amounts of poppy seeds will be well nether the detection threshold.
IA is not-specific and cross-reactions can occur. As an case, quinolone antibiotics tin can cross react with an opioid panel yielding a simulated positive test upshot. To eliminate this type of mistake, IA tests should be confirmed with a more than definitive chromatographic test (e.m., GC-MS), particularly if a exam result is unexpected and does not correlate with a patient's history.
b. Interpretation of confirmatory chromatography tests
Chromatographic tests generally take longer to perform, are more than labor intensive and more expensive than IA, though newer technologies may address these issues. Chromatographic tests are specific and are non susceptible to cross-reactions, thus simulated positive results are rare. However, chromatographic tests can notice prescribed medications (such as stimulants used for ADHD treatment) and it is impossible to distinguish whether a patient used the medication as prescribed or misused information technology past using more prescribed or using an alternating route of assistants (e.1000., crushing and snorting pills).
c. Interpretation of negative tests
Whether IA or chromatographic testing is preformed, special consideration should be given to the interpretation of negative tests. A drug examination volition be negative despite ongoing drug apply in four dissimilar circumstances:
-
The window of detection has passed. The window of detection for near substances is 2-three days and drug utilise will non be detected after this menses. One notable exception is heavy, chronic utilise of cannabis, which can result in prolonged excretion for up to 4 weeks [14], complicating estimation during this period.
-
The patient has used a substance not detected by the testing panel. While most any substance can be tested for in urine, standard test panels are limited to commonly used substances. For example, constructed cannabinoids are not detected by standard tests for cannabis and should be ordered separately if utilize is suspected. Inhalants are excreted past the lungs and cannot exist detected in a urine specimen.
-
The concentration of the substance is beneath the detection limit of the test. This is uncommon with chromatographic tests which are typically very sensitive, only may occur with IA tests which have a set cut-off threshold typically designed to eliminate false positives from cross-reaction or trace amounts of a drug or metabolite that may exist constitute in food products. Intentional urine dilution may consequence in a falsely negative examination.
-
The specimen has been substituted or adulterated. Distinct from most instances of laboratory medicine, patients may be motivated to falsify test results by substituting or adulterating specimens. Proper specimen drove techniques (see above), employ of temperature testing, and adulterant panels can minimize opportunities for interfering with testing in this way.
d. Presenting drug test results to adolescents
Reviewing positive urine drug test results presents the simultaneous challenges of sharing relevant information while maintaining a therapeutic alliance with an boyish patient and his or her family. Prior to ordering a drug test, a discussion of how results volition be reported and to whom can help maximize the utility of drug testing.
In most instances it is useful to have a private conversation with the adolescent to clarify interpretation of the drug examination issue. Simply sharing that the drug test yielded an "unexpected consequence" without revealing specific details may set the stage for an honest conversation near substance utilise, and at times, patients will reveal employ of substances that were non detected by the test. If the patient gives a history that is consequent with the drug examination results the conversation tin can move on to a word of next steps – which could include changes to the handling plan. Sharing drug test results together with a program may facilitate a positive conversation. For instance, a clinician may report to a parent that their son has recently used marijuana and has now agreed to speak with a counselor about feet and marijuana use.
When a drug examination result is dilute or otherwise cryptic a clinical interview may be helpful. Starting with a elementary statement about an "unexpected test result" without revealing all of the details tin can serve every bit an open-ended way of offset the chat. If a patient does not report substance use the clinician tin review methods for reducing the chance of a dilute specimen – by providing a commencement morning urine if possible, or if non, limiting water intake in the hour prior to giving a sample. Repeat testing may be useful.
During a clinical interview an adolescent may offer an caption that is consequent with the observed drug exam results, such as a new prescription medication or supervised use of cold medication. This history can be confirmed with a parent and the drug test can be interpreted as negative (i.east., consistent with a history of no illicit substance use).
In some instances an adolescent'southward history may exist inconsistent with observed drug test results. As with all laboratory testing, drug examination results provide limited information and clinical correlation is always advised. A single positive drug test may exist spurious and tin be treated that way if the patient otherwise seems to be doing well and adhering to the handling plan. In these cases repeat urine testing is recommended; a second occurrence of a positive drug test is unlikely to exist another simulated-positive result. In this case, the clinician may recommend modifications to the treatment program.
Decision
Drug testing, when carefully collected and thoughtfully interpreted, offers a critical adjunct to clinical intendance and substance use handling (Box 1). Nevertheless, because test results can be misleading if not interpreted in the right clinical context, clinicians should always conduct a careful interview with adolescent patients to understand what testing is likely to show and so employ testing to validate or refute their expectations. Due to the ease with which samples can be tampered, providers should too advisedly reflect on their ain collection protocols and sample validation procedures to ensure optimal accuracy.
Acknowledgments
Dr. Hadland is supported by the Division of Adolescent and Young Developed Medicine at Boston Children's Hospital and the Leadership Education in Adolescent Health Training Program T71 MC00009 (MCH/HRSA) and past a National Research Service Award 1T32 HD075727 (NIH/NICHD). Dr. Levy is supported past 1R01AA021913–01 (NIH/NIAAA).
Footnotes
Conflict of Interest Statement
The authors take no conflicts of interest to disclose.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. Equally a service to our customers we are providing this early version of the manuscript. The manuscript volition undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Delight note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
one. Moyer VA. Screening and behavioral counseling interventions in primary intendance to reduce alcohol misuse: U.South. preventive services task force recommendation statement. Ann Intern Med. 2013;159:210–eight. [PubMed] [Google Scholar]
two. National Institute on Alcohol Abuse and Alcoholism. Alcohol Screening and Brief Intervention for Youth: A Practitioner'due south Guide. Bethesda, MD: 2011. [Google Scholar]
iii. Higgins-Biddle J, Hungerford D, Cates-Wessel 1000. Screening and Cursory Interventions (SBI) for Unhealthy Alcohol Use: A Footstep-by-Step Implementation Guide for Trauma Centers. Atlanta, GA: 2009. [Google Scholar]
4. Levy SJ, Kokotailo PK. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128:e1330–forty. [PubMed] [Google Scholar]
5. Levy S. Furnishings of marijuana policy on children and adolescents. JAMA Pediatr. 2013;167:600–2. [PubMed] [Google Scholar]
vii. Levy Southward, Siqueira LM, Ammerman SD, et al. Testing for drugs of abuse in children and adolescents. Pediatrics. 2014;133:e1798–807. [PubMed] [Google Scholar]
viii. American Society for Addiction Medicine. Drug Testing: A White Newspaper of the American Society of Habit Medicine (ASAM) Chevy Chase, Medico: 2013. [Google Scholar]
nine. Substance Abuse and Mental Health Services Administration. Clinical Drug Testing in Primary Care Technical Help Publication (TAP) 32 HHS Publication No (SMA) 12-4668. Rockville, MD: 2012. [Google Scholar]
11. Levy S, Harris SK, Sherritt Fifty, et al. Drug testing of adolescents in ambulatory medicine: md practices and knowledge. Curvation Pediatr Adolesc Med. 2006;160:146–l. [PubMed] [Google Scholar]
12. Jones RK, Shinar D, Walsh JM. Detection and Measurement of Drugs State Knowl Drug-Dumb Driving, NHTSA Rep DOT HS 809 642. Washington, DC: The states National Highway Traffic Safety Assistants; 2003. [Google Scholar]
13. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327–lx. [PubMed] [Google Scholar]
14. Schwilke EW, Gullberg RG, Darwin WD, et al. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction. 2011;106:499–506. [PMC free article] [PubMed] [Google Scholar]
15. Cone EJ. New Developments in Biological Measures of Drug Prevalence. In: Harrison L, Hughes A, editors. Validity Self-Reported Drug Use Improv Accuracy Surv Estim. Bethesda, Medico: National Institute on Drug Abuse; 1997. [Google Scholar]
sixteen. Dams R, Choo RE, Lambert Nosotros, et al. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-corruption treatment patients. Drug Alcohol Depend. 2007;87:258–67. [PMC free article] [PubMed] [Google Scholar]
xix. Boumba V, Ziavrou M, Vougiouklakis T. Pilus every bit a Biological Indicator of Drug Use, Drug Abuse or Chronic Exposure to Environmental Toxicants. Int J Toxicol. 2006;25:143–63. [PubMed] [Google Scholar]
xx. Dolan Thou, Rouen D, Kimber J. An overview of the apply of urine, hair, sweat and saliva to detect drug use. Drug Alcohol Rev. 2004;23:213–7. [PubMed] [Google Scholar]
21. Warner E, Lorch E. Laboratory Diagnosis. In: Ries RK, Fiellin DA, Miller SC, et al., editors. ASAM Princ Addict Med. v. Philadelphia, PA: 2014. [Google Scholar]
22. Pragst F, Balikova MA. State of the fine art in pilus analysis for detection of drug and alcohol corruption. Clin Chim Acta. 2006;370:17–49. [PubMed] [Google Scholar]
23. Henderson GL, Harkey MR, Zhou C, et al. Incorporation of isotopically labeled cocaine and metabolites into human hair: 1. dose-response relationships. J Anal Toxicol. xx:ane–12. [PubMed] [Google Scholar]
24. Ropero-Miller JD, Huestis MA, Stout PR. Cocaine analytes in human pilus: evaluation of concentration ratios in dissimilar cocaine sources, drug-user populations and surface-contaminated specimens. J Anal Toxicol. 2012;36:390–8. [PubMed] [Google Scholar]
25. Dasgupta A. Handbook of Drug Monitoring Methods: Therapeutics and Drugs of Corruption. Totowa, NJ: 2008. [Google Scholar]
26. Pötsch Fifty, Skopp G, Moeller MR. Influence of pigmentation on the codeine content of hair fibers in republic of guinea pigs. J Forensic Sci. 1997;42:1095–8. [PubMed] [Google Scholar]
28. Concheiro M, Jones HE, Johnson RE, et al. Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. Ther Drug Monit. 2010;32:206–15. [PMC free article] [PubMed] [Google Scholar]
29. Gray T, Huestis G. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem. 2007;388:1455–65. [PMC free commodity] [PubMed] [Google Scholar]
30. Hudak ML, Tan RC. Neonatal Drug Withdrawal. Pediatrics. 2012;129:e540–lx. [PubMed] [Google Scholar]
31. Stanger C, Budney AJ. Contingency management approaches for boyish substance utilise disorders. Child Adolesc Psychiatr Clin N Am. 2010;xix:547–62. [PMC costless article] [PubMed] [Google Scholar]
32. Hartzler B, Lash SJ, Roll JM. Contingency management in substance abuse treatment: a structured review of the testify for its transportability. Drug Alcohol Depend. 2012;122:i–10. [PMC free article] [PubMed] [Google Scholar]
33. Shearer J, Tie H, Byford Southward. Economical evaluations of contingency management in illicit drug misuse programmes: A systematic review. Drug Alcohol Rev. 2015;34:289–98. [PubMed] [Google Scholar]
34. Dennis M, Godley SH, Diamond G, et al. The Cannabis Youth Handling (CYT) Study: main findings from two randomized trials. J Subst Abuse Care for. 2004;27:197–213. [PubMed] [Google Scholar]
36. Levy South, Schizer M. Boyish Drug Testing Policies in Schools. Pediatrics. 2015;135:782–3. [PubMed] [Google Scholar]
37. Center for Substance Abuse Handling. Substance Abuse and Mental Health Administration. Rockville, Doctor: 1999. Chapter 8—Legal and Upstanding Issues. [Google Scholar]
39. Johnston LD, O'Malley PM, Miech RA, et al. Monitoring the Future National Results on Drug Apply: 2014 Overview. Fundamental Findings on Boyish Drug Use [Google Scholar]
40. Rengarajan A, Mullins ME. How often do simulated-positive phencyclidine urine screens occur with utilise of mutual medications? Clin Toxicol. 2013;51:493–6. [PMC gratis article] [PubMed] [Google Scholar]
41. Nanau RM, Neuman MG. Biomolecules and Biomarkers Used in Diagnosis of Booze Drinking and in Monitoring Therapeutic Interventions. Biomolecules. 2015;5:1339–85. [PMC free commodity] [PubMed] [Google Scholar]
42. Warner Due east. Princ Addict Med. 3. Chevy Hunt, Dr.: American Society of Addiction Medicine; 2003. Laboratory Diagnosis; pp. 337–48. [Google Scholar]
43. Eye for Substance Abuse Treatment. The Role of Biomarkers in the Treatment of Alcohol Utilise Disorders. Rockville, Doctor: 2006. [Google Scholar]
44. Kwong TC, Ryan RM. Detection of intrauterine illicit drug exposure by newborn drug testing. National University of Clinical Biochemistry. Clin Chem. 1997;43:235–42. [PubMed] [Google Scholar]
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920965/
0 Response to "What Are Art Tablets Used for in Urine Tests"
Post a Comment